Goldman Sachs Group Inc Direxion Daily S&P Biotech Bea Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Goldman Sachs Group Inc holds 52,358 shares of LABD stock, worth $303,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,358Holding current value
$303,152% of portfolio
0.0%Shares
18 transactions
Others Institutions Holding LABD
# of Institutions
25Shares Held
1.48MCall Options Held
1.55MPut Options Held
269K-
Jane Street Group, LLC New York, NY337KShares$1.95 Million0.0% of portfolio
-
Virtu Financial LLC New York, NY260KShares$1.5 Million0.1% of portfolio
-
Chi Advisors LLC New York, NY225KShares$1.3 Million2.28% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il212KShares$1.23 Million0.0% of portfolio
-
Jump Financial, LLC Chicago, IL174KShares$1.01 Million0.02% of portfolio